🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Shahneen Sandhu

The University of Melbourne

ORCID: 0000-0002-8660-4475

Also affiliated with Peter MacCallum Cancer Centre

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

The MURAL collection of prostate cancer patient-derived xenografts enables discovery through preclinical models of uro-oncology

Nature Communications(2021)10.1038/s41467-021-25175-5
Top 31%
0.644DataRank
Top 31%72 citations

Ashlee K. Clark, Laura H. Porter, Roxanne Toivanen, Andrew Bakshi, Natalie L. Lister +40 more

Papers

Driven by 9 papers — median percentile 69. Top paper: “Niraparib in patients with metastatic castration-resistant prostate cancer and DNA repair gene defects (GALAHAD): a multicentre, open-label, phase 2 trial”.

Niraparib in patients with metastatic castration-resistant prostate cancer and DNA repair gene defects (GALAHAD): a multicentre, open-label, phase 2 trial

The Lancet Oncology(2022)10.1016/s1470-2045(21)00757-9
N/A
4.9DataRank · unranked
188 citations

Howard I Scher, Shahneen Sandhu, Eleni Efstathiou, Primo N Lara, Evan Y Yu +90 more

Management of early melanoma recurrence despite adjuvant anti-PD-1 antibody therapy☆

Annals of Oncology(2020)10.1016/j.annonc.2020.04.471
N/A
3.5DataRank · unranked
110 citations

Alexander N. Shoushtari, D Chauhan, David Palmieri, Belinda Lee, Maartje W. Rohaan +20 more

Immune checkpoint inhibitor-associated myocarditis: a novel risk score

European Heart Journal(2025)10.1093/eurheartj/ehaf315
N/A
1.1DataRank · unranked
47 citations

Charles Dolladille, Benay Ozbay, Adrien Procureur, Stéphane Éderhy, Nicolas L. Palaskas +92 more

The MURAL collection of prostate cancer patient-derived xenografts enables discovery through preclinical models of uro-oncology

Nature Communications(2021)10.1038/s41467-021-25175-5
Top 31%
0.644DataRank
Top 31%72 citations

Ashlee K. Clark, Laura H. Porter, Roxanne Toivanen, Andrew Bakshi, Natalie L. Lister +40 more

Efficacy of immune checkpoint inhibitors for the treatment of advanced melanoma in patients with concomitant chronic lymphocytic leukemia

Annals of Oncology(2023)10.1016/j.annonc.2023.06.007
N/A
0.396DataRank · unranked
13 citations

Joshua W.D. Tobin, Yongwoo David Seo, Georgina Gener‐Ricos, Emily Z. Keung, Elizabeth M. Burton +28 more

Predictors and Risk Score for Immune Checkpoint-Inhibitor-Associated Myocarditis Severity

medRxiv(2024)10.1101/2024.06.02.24308336
N/A
0.383DataRank · unranked
6 citations

Charles Dolladille, Adriel Procureur, Stéphane Éderhy, Nicolas L. Palaskas, Lorenz Lehmann +47 more

Immune Checkpoint Inhibitor Myocarditis and Left Ventricular Systolic Dysfunction

JACC CardioOncology(2025)10.1016/j.jaccao.2025.01.020
N/A
0DataRank · unranked
21 citations

Charles Dolladille, Anjali Rao, Nicolas L. Palaskas, Anita Deswal, Lorenz Lehmann +51 more

Intraindividual epigenetic heterogeneity underlying phenotypic subtypes of advanced prostate cancer

Nature Communications(2025)10.1038/s41467-025-60654-z
N/A
0DataRank · unranked
9 citations

Sheng-Yu Ku, Varadha Balaji Venkadakrishnan, Martin Bakht, Michael Sigouros, Joanna Chan +18 more

Meeting report from the Prostate Cancer Foundation PSMA theranostics state of the science meeting

The Prostate(2020)10.1002/pros.24056
N/A
0DataRank · unranked
28 citations

Kenneth J. Pienta, John W. Babich, Neil H. Bander, Jérémie Calais, Peter L. Choyke +11 more